Eli Lilly’s Mounjaro Becomes India’s 2nd Highest Selling Drug in September 2025
Mounjaro’s 42% month-on-month sales growth propels it to the position of India’s second top-selling drug in September 2025, highlighting a strong market shift towards innovative obesity management treatments.